Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Rob Ter Heine

Showing results (121-130 of 160) with videos related to

Pageof 16
Sort By:
The Journal of Infectious Diseases|April 12, 2023
Modeling the Impact of a Highly Potent Plasmodium falciparum Transmission-Blocking Monoclonal Antibody in Areas of Seasonal Malaria TransmissionJoseph D Challenger, Stijn W van Beek, Rob Ter Heine, et al.
Clinical Journal of the American Society of Nephrology : CJASN|March 13, 2023
Proteinuria and Exposure to Eculizumab in Atypical Hemolytic Uremic SyndromeMendy Ter Avest, Hilbert Steenbreker, Romy N Bouwmeester, et al.
Journal of the International AIDS Society|June 10, 2020
Drug level testing as a strategy to determine eligibility for drug resistance testing after failure of ART: a retrospective analysis of South African adult patients on second-line ARTLucas E Hermans, Kim Steegen, Rob Ter Heine, et al.
Clinical Pharmacokinetics|February 14, 2019
Pharmacology, Pharmacokinetics and Pharmacodynamics of Eculizumab, and Possibilities for an Individualized Approach to EculizumabKioa Lente Wijnsma, Rob Ter Heine, Dirk Jan A R Moes, et al.
Targeted Oncology|July 31, 2024
An Evidence-Based Rationale for Dose De-escalation of Subcutaneous AtezolizumabMart P Kicken, Maarten J Deenen, Dirk J A R Moes, et al.
Translational Psychiatry|February 13, 2019
Neurodevelopmental and behavioral consequences of perinatal exposure to the HIV drug efavirenz in a rodent modelLisa van de Wijer, Lidiane P Garcia, Sabrina I Hanswijk, et al.
Therapeutic Drug Monitoring|April 29, 2025
Pharmacokinetic Study of Carboplatin Using Various Overweight-Correcting Dosing Algorithms and Biomarkers in Patients With Varying BMI CategoriesMart P Kicken, Corine Bethlehem, Karin Beunen, et al.
Cancer Chemotherapy and Pharmacology|February 25, 2025
Model-informed development of a cost-saving dosing regimen for enfortumab vedotinCatharina Jp Op 't Hoog, Amy Rieborn, Dirk Jan Ar Moes, et al.
Pediatric Nephrology (Berlin, Germany)|August 2, 2022
Glomerular filtration rate in critically ill neonates and children: creatinine-based estimations versus iohexol-based measurementsNori J L Smeets, Esther M M Teunissen, Kim van der Velden, et al.
Pediatric Research|July 23, 2020
The bioavailability and maturing clearance of doxapram in preterm infantsRobert B Flint, Sinno H P Simons, Peter Andriessen, et al.
Pageof 16

Showing results (121-130 of 160) with videos related to

Sort By:
Pageof 16
The Journal of Infectious Diseases|April 12, 2023
Modeling the Impact of a Highly Potent Plasmodium falciparum Transmission-Blocking Monoclonal Antibody in Areas of Seasonal Malaria TransmissionJoseph D Challenger, Stijn W van Beek, Rob Ter Heine, et al.
Clinical Journal of the American Society of Nephrology : CJASN|March 13, 2023
Proteinuria and Exposure to Eculizumab in Atypical Hemolytic Uremic SyndromeMendy Ter Avest, Hilbert Steenbreker, Romy N Bouwmeester, et al.
Journal of the International AIDS Society|June 10, 2020
Drug level testing as a strategy to determine eligibility for drug resistance testing after failure of ART: a retrospective analysis of South African adult patients on second-line ARTLucas E Hermans, Kim Steegen, Rob Ter Heine, et al.
Clinical Pharmacokinetics|February 14, 2019
Pharmacology, Pharmacokinetics and Pharmacodynamics of Eculizumab, and Possibilities for an Individualized Approach to EculizumabKioa Lente Wijnsma, Rob Ter Heine, Dirk Jan A R Moes, et al.
Targeted Oncology|July 31, 2024
An Evidence-Based Rationale for Dose De-escalation of Subcutaneous AtezolizumabMart P Kicken, Maarten J Deenen, Dirk J A R Moes, et al.
Translational Psychiatry|February 13, 2019
Neurodevelopmental and behavioral consequences of perinatal exposure to the HIV drug efavirenz in a rodent modelLisa van de Wijer, Lidiane P Garcia, Sabrina I Hanswijk, et al.
Therapeutic Drug Monitoring|April 29, 2025
Pharmacokinetic Study of Carboplatin Using Various Overweight-Correcting Dosing Algorithms and Biomarkers in Patients With Varying BMI CategoriesMart P Kicken, Corine Bethlehem, Karin Beunen, et al.
Cancer Chemotherapy and Pharmacology|February 25, 2025
Model-informed development of a cost-saving dosing regimen for enfortumab vedotinCatharina Jp Op 't Hoog, Amy Rieborn, Dirk Jan Ar Moes, et al.
Pediatric Nephrology (Berlin, Germany)|August 2, 2022
Glomerular filtration rate in critically ill neonates and children: creatinine-based estimations versus iohexol-based measurementsNori J L Smeets, Esther M M Teunissen, Kim van der Velden, et al.
Pediatric Research|July 23, 2020
The bioavailability and maturing clearance of doxapram in preterm infantsRobert B Flint, Sinno H P Simons, Peter Andriessen, et al.
Pageof 16